Symbols / IXHL
IXHL Chart
About
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 60.20M |
| Enterprise Value | 29.45M | Income | -48.50M | Sales | — |
| Book/sh | 0.20 | Cash/sh | 0.19 | Dividend Yield | — |
| Payout | 0.00% | Employees | 12 | IPO | — |
| P/E | — | Forward P/E | -0.09 | PEG | — |
| P/S | inf | P/B | 0.82 | P/C | — |
| EV/EBITDA | -1.16 | EV/Sales | — | Quick Ratio | 47.96 |
| Current Ratio | 48.27 | Debt/Eq | 0.22 | LT Debt/Eq | — |
| EPS (ttm) | -0.74 | EPS next Y | -1.96 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-02-13 07:00 | ROA | -36.96% |
| ROE | -130.43% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 358.33M |
| Shs Float | 314.28M | Short Float | 6.35% | Short Ratio | 2.94 |
| Short Interest | — | 52W High | 1.66 | 52W Low | 0.08 |
| Beta | 2.59 | Avg Volume | 13.62M | Volume | 27.15M |
| Target Price | — | Recom | Strong_buy | Prev Close | $0.27 |
| Price | $0.17 | Change | -38.69% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.17
Latest analyst target
3. DCF / Fair value
$-0.47
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.17
Low
—
High
—
Mean
—
- Incannex Healthcare Announces 1-for-30 Reverse Stock Split - TipRanks Wed, 25 Feb 2026 13
- Why Did IXHL Stock Tank Over 32% Today? - Stocktwits Wed, 25 Feb 2026 14
- Incannex Healthcare Inc. Announces 1-for-30 Reverse Stock Split to Regain Nasdaq Compliance - Quiver Quantitative Wed, 25 Feb 2026 14
- Inside the expert panel steering Incannex’s next PSX-001 trials - Stock Titan hu, 29 Jan 2026 08
- What Makes Incannex Healthcare Inc. (IXHL) a New Buy Stock - Yahoo Finance Mon, 01 Dec 2025 08
- Why Did IXHL Stock Tank Over 32% Today? - Asianet Newsable Wed, 25 Feb 2026 15
- Incannex to effect 1-for-30 reverse stock split to regain Nasdaq compliance - MSN Wed, 25 Feb 2026 15
- Incannex Healthcare approved 1-for-30 reverse stock split - marketscreener.com Wed, 25 Feb 2026 14
- Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Large Growth in Short Interest - MarketBeat Mon, 16 Feb 2026 08
- Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks - TechStock² hu, 04 Dec 2025 08
- IXHL - Incannex Healthcare Ltd Latest Stock News & Market Updates - Stock Titan hu, 20 Nov 2025 08
- Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026 - Yahoo Finance hu, 20 Nov 2025 08
- Incannex Healthcare (NASDAQ:IXHL) Announces Quarterly Earnings Results - MarketBeat Fri, 13 Feb 2026 08
- ANNEX HEALTHCARE LIMITED Earnings Preview: Recent $IXHL Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative Wed, 24 Sep 2025 07
- Incannex (Nasdaq: IXHL) posts PSX-001 Phase 2 GAD results with 11-week relief, no SAEs - Stock Titan hu, 30 Oct 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 22608692 | — | — | Stock Award(Grant) at price 0.00 per share. | LATHAM JOEL | Chief Executive Officer | — | 2025-11-14 00:00:00 | D |
| 1 | 1686956 | — | — | Stock Award(Grant) at price 0.00 per share. | ANASTASSOV GEORGE | Director | — | 2025-11-14 00:00:00 | D |
| 2 | 11302608 | — | — | Stock Award(Grant) at price 0.00 per share. | VALENTINE TROY ROBERT | Director | — | 2025-11-14 00:00:00 | D |
| 3 | 869565 | — | — | Stock Award(Grant) at price 0.00 per share. | SWAN JOSEPH | Chief Financial Officer | — | 2025-11-14 00:00:00 | D |
| 4 | 1686956 | — | — | Stock Award(Grant) at price 0.00 per share. | SWAN JOSEPH | Director | — | 2025-11-14 00:00:00 | D |
| 5 | 1686956 | — | — | Stock Award(Grant) at price 0.00 per share. | WIDDOWS PETER | Director | — | 2025-11-14 00:00:00 | D |
| 6 | 100476 | — | — | Stock Award(Grant) at price 0.00 per share. | SWAN JOSEPH | Officer | — | 2024-10-23 00:00:00 | D |
| 7 | 50793 | — | — | Stock Award(Grant) at price 0.00 per share. | SWAN JOSEPH | Chief Financial Officer | — | 2024-05-06 00:00:00 | D |
Financials
| Line Item | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -8.40K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.30 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -22.65M | -18.30M | 21.86M | -10.07M |
| TotalUnusualItems | -23.69M | -28.00K | -35.41M | -92.61K |
| TotalUnusualItemsExcludingGoodwill | -23.69M | -28.00K | -35.41M | -92.61K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -18.46M | -48.81M | -10.25M | -8.54M |
| ReconciledDepreciation | 103.00K | 88.00K | 0.00 | 0.00 |
| ReconciledCostOfRevenue | 0.00 | 4.36K | 685.20K | |
| EBITDA | -18.33M | -13.55M | -10.16M | -8.57M |
| EBIT | -18.43M | -13.64M | -10.16M | -8.57M |
| NetInterestIncome | 206.00K | 241.00K | 4.31K | 2.01K |
| InterestIncome | 206.00K | 241.00K | 4.31K | 2.01K |
| NormalizedIncome | -23.20M | -18.44M | -13.40M | -10.16M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -18.46M | -48.81M | -10.25M | -8.54M |
| TotalExpenses | 18.62M | 13.64M | 10.16M | 10.00M |
| RentExpenseSupplemental | 348.00K | 84.00K | 77.28K | 87.03K |
| TotalOperatingIncomeAsReported | -30.04M | -49.67M | ||
| DilutedAverageShares | 34.45M | 16.16M | 15.87M | 297.79M |
| BasicAverageShares | 34.45M | 16.16M | 15.87M | 297.79M |
| DilutedEPS | -1.35 | -1.15 | -0.03 | -0.03 |
| BasicEPS | -1.35 | -1.15 | -0.03 | -0.03 |
| DilutedNIAvailtoComStockholders | -18.46M | -48.81M | -10.25M | -8.54M |
| NetIncomeCommonStockholders | -18.46M | -48.81M | -10.25M | -8.54M |
| NetIncome | -18.46M | -48.81M | -10.25M | -8.54M |
| NetIncomeIncludingNoncontrollingInterests | -18.46M | -48.81M | -10.25M | -8.54M |
| NetIncomeContinuousOperations | -18.46M | -48.81M | -10.25M | -8.54M |
| TaxProvision | 30.00K | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -18.43M | -48.81M | -10.25M | -8.54M |
| OtherIncomeExpense | -28.00K | -35.41M | -92.61K | 26.72K |
| OtherNonOperatingIncomeExpenses | -796.00K | 1.38M | 788.65K | 26.72K |
| SpecialIncomeCharges | 0.00 | -35.35M | -92.61K | 0.00 |
| OtherSpecialCharges | 35.35M | |||
| WriteOff | 0.00 | 92.61K | 0.00 | |
| GainOnSaleOfSecurity | -22.21M | -28.00K | -67.00K | |
| NetNonOperatingInterestIncomeExpense | 206.00K | 241.00K | 4.31K | 2.01K |
| InterestIncomeNonOperating | 206.00K | 241.00K | 4.31K | 2.01K |
| OperatingIncome | -18.61M | -13.64M | -10.16M | -8.57M |
| OperatingExpense | 18.62M | 13.64M | 10.16M | 9.31M |
| OtherOperatingExpenses | -11.43M | -683.00K | -28.18K | |
| OtherTaxes | -671.12K | -538.21K | 0.00 | |
| DepreciationAmortizationDepletionIncomeStatement | 103.00K | 88.00K | 0.00 | |
| DepreciationAndAmortizationInIncomeStatement | 103.00K | 88.00K | 0.00 | |
| DepreciationIncomeStatement | 103.00K | 88.00K | 0.00 | |
| ResearchAndDevelopment | 12.88M | 6.31M | 3.70M | 3.57M |
| SellingGeneralAndAdministration | 17.07M | 7.92M | 7.00M | 5.77M |
| SellingAndMarketingExpense | 1.05M | 1.25M | 1.89M | 3.27M |
| GeneralAndAdministrativeExpense | 16.02M | 6.67M | 5.11M | 2.51M |
| OtherGandA | 3.93M | 2.09M | 2.64M | 996.53K |
| RentAndLandingFees | 348.00K | 84.00K | 77.28K | 87.03K |
| SalariesAndWages | 11.74M | 4.50M | 2.39M | 1.42M |
| GrossProfit | 0.00 | -4.36K | 740.54K | |
| CostOfRevenue | 0.00 | 4.36K | 685.20K | |
| TotalRevenue | 12.00K | 0.00 | 0.00 | 1.43M |
| OperatingRevenue | 12.00K | 0.00 | 0.00 | 1.43M |
| Line Item | 2023-06-30 | 2022-06-30 | ||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | 0.00 | ||
| OrdinarySharesNumber | 17.64M | 15.87M | 12.92M | 10.68M |
| ShareIssued | 17.64M | 15.87M | 12.92M | 10.68M |
| TotalDebt | 373.00K | 521.00K | 0.00 | |
| TangibleBookValue | 11.22M | 20.82M | 24.67M | 6.44M |
| InvestedCapital | 11.22M | 20.82M | 24.67M | 6.44M |
| WorkingCapital | 10.58M | 20.45M | 24.67M | 6.44M |
| NetTangibleAssets | 11.22M | 20.82M | 24.67M | 6.44M |
| CapitalLeaseObligations | 373.00K | 521.00K | 0.00 | |
| CommonStockEquity | 11.22M | 20.82M | 24.67M | 6.44M |
| TotalCapitalization | 11.22M | 20.82M | 24.67M | 6.44M |
| TotalEquityGrossMinorityInterest | 11.22M | 20.82M | 24.67M | 6.44M |
| StockholdersEquity | 11.22M | 20.82M | 24.67M | 6.44M |
| OtherEquityInterest | 7.98M | 5.56M | 4.97M | |
| GainsLossesNotAffectingRetainedEarnings | -3.33M | -3.25M | 3.32M | |
| OtherEquityAdjustments | 3.32M | |||
| ForeignCurrencyTranslationAdjustments | -3.33M | -3.25M | ||
| RetainedEarnings | -110.67M | -92.21M | -40.45M | -32.98M |
| AdditionalPaidInCapital | 125.22M | 116.29M | ||
| CapitalStock | 2.00K | 2.00K | 59.56M | 34.45M |
| CommonStock | 2.00K | 2.00K | 59.56M | 34.45M |
| PreferredStock | 0.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 5.83M | 2.96M | 1.38M | 567.30K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 210.00K | 408.00K | 0.00 | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 210.00K | 408.00K | 0.00 | |
| LongTermCapitalLeaseObligation | 210.00K | 408.00K | 0.00 | |
| CurrentLiabilities | 5.62M | 2.55M | 1.38M | 567.30K |
| CurrentDeferredLiabilities | 85.00K | 0.00 | ||
| CurrentDeferredRevenue | 85.00K | 0.00 | ||
| CurrentDebtAndCapitalLeaseObligation | 163.00K | 113.00K | ||
| CurrentCapitalLeaseObligation | 163.00K | 113.00K | 0.00 | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 333.00K | 263.00K | 202.51K | 105.35K |
| PayablesAndAccruedExpenses | 5.04M | 2.17M | 1.18M | 461.95K |
| CurrentAccruedExpenses | 4.51M | 426.00K | 285.79K | 286.80K |
| Payables | 527.00K | 1.75M | 894.76K | 175.15K |
| OtherPayable | 521.93K | |||
| AccountsPayable | 527.00K | 1.75M | 894.76K | 175.15K |
| TotalAssets | 17.05M | 23.78M | 26.06M | 7.01M |
| TotalNonCurrentAssets | 845.00K | 786.00K | 0.00 | 0.00 |
| GoodwillAndOtherIntangibleAssets | 34.90M | 0.00 | ||
| NetPPE | 845.00K | 786.00K | 0.00 | |
| AccumulatedDepreciation | -126.00K | -23.00K | ||
| GrossPPE | 971.00K | 809.00K | 0.00 | |
| ConstructionInProgress | 0.00 | 160.00K | ||
| OtherProperties | 1.19M | |||
| MachineryFurnitureEquipment | 598.00K | 157.00K | ||
| BuildingsAndImprovements | 373.00K | 492.00K | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 16.20M | 23.00M | 26.06M | 7.01M |
| OtherCurrentAssets | 1.04M | |||
| PrepaidAssets | 329.00K | 686.00K | 41.16K | 27.12K |
| Receivables | 10.02M | 191.00K | 219.33K | 127.04K |
| OtherReceivables | 40.16K | |||
| TaxesReceivable | 10.02M | 191.00K | 202.74K | 86.89K |
| NotesReceivable | 66.20K | 16.60K | 0.00 | |
| AccountsReceivable | 287.48K | 53.45K | ||
| GrossAccountsReceivable | 53.45K | |||
| CashCashEquivalentsAndShortTermInvestments | 5.86M | 22.12M | 25.80M | 6.85M |
| CashAndCashEquivalents | 5.86M | 22.12M | 25.80M | 6.85M |
| CashFinancial | 22.08M | 25.80M | 6.85M |
| Line Item | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -16.12M | -11.06M | -8.81M | -5.19M |
| RepaymentOfDebt | -36.22K | 0.00 | ||
| IssuanceOfCapitalStock | 0.00 | 8.18M | 28.33M | 9.32M |
| CapitalExpenditure | -277.00K | -316.00K | ||
| EndCashPosition | 5.86M | 22.12M | 25.80M | 6.85M |
| BeginningCashPosition | 22.12M | 25.83M | 6.28M | 2.71M |
| EffectOfExchangeRateChanges | -140.00K | -824.00K | 0.00 | 0.00 |
| ChangesInCash | -16.12M | -2.89M | 19.52M | 4.15M |
| FinancingCashFlow | 0.00 | 8.18M | 28.33M | 9.32M |
| CashFlowFromContinuingFinancingActivities | 0.00 | 8.18M | 28.33M | 9.32M |
| NetCommonStockIssuance | 0.00 | 8.18M | 28.33M | 9.32M |
| CommonStockIssuance | 0.00 | 8.18M | 28.33M | 9.32M |
| NetIssuancePaymentsOfDebt | -36.22K | 0.00 | ||
| NetLongTermDebtIssuance | -36.22K | 0.00 | ||
| LongTermDebtPayments | -36.22K | 0.00 | ||
| InvestingCashFlow | -277.00K | -316.00K | 0.00 | 22.00K |
| CashFlowFromContinuingInvestingActivities | -277.00K | -316.00K | 0.00 | 22.00K |
| NetBusinessPurchaseAndSale | 0.00 | 22.00K | ||
| SaleOfBusiness | 0.00 | 22.00K | ||
| NetPPEPurchaseAndSale | -277.00K | -316.00K | 0.00 | 0.00 |
| SaleOfPPE | 0.00 | 0.00 | ||
| PurchaseOfPPE | -277.00K | -316.00K | 0.00 | |
| OperatingCashFlow | -15.85M | -10.75M | -8.81M | -5.19M |
| CashFlowFromContinuingOperatingActivities | -15.85M | -10.75M | -8.81M | -5.19M |
| ChangeInWorkingCapital | -6.45M | 35.83M | 843.64K | 4.33K |
| ChangeInOtherCurrentLiabilities | 68.33K | 106.06K | -76.01K | |
| ChangeInOtherCurrentAssets | 0.00 | 35.35M | 36.77K | 129.23 |
| ChangeInPayablesAndAccruedExpense | 3.02M | 1.10M | 764.32K | -218.87K |
| ChangeInPayable | 3.02M | 1.10M | ||
| ChangeInPrepaidAssets | 369.00K | -626.00K | ||
| ChangeInInventory | 0.00 | 137.61K | ||
| ChangeInReceivables | -9.84M | 0.00 | -63.51K | 161.46K |
| OtherNonCashItems | -4.25K | -408.89K | 2.91M | |
| StockBasedCompensation | 8.93M | 2.15M | 1.01M | 450.83K |
| ProvisionandWriteOffofAssets | 0.00 | -11.63K | ||
| DepreciationAmortizationDepletion | 103.00K | 88.00K | 0.00 | 0.00 |
| DepreciationAndAmortization | 103.00K | 88.00K | 0.00 | 0.00 |
| OperatingGainsLosses | 28.00K | |||
| NetForeignCurrencyExchangeGainLoss | 28.00K | 0.00 | ||
| NetIncomeFromContinuingOperations | -18.46M | -48.81M | -10.25M | -8.54M |
| CashFlowsfromusedinOperatingActivitiesDirect | -15.94M | -12.81M | -5.19M | |
| InterestReceivedDirect | 329.16K | 6.27K | 73.07K | |
| ClassesofCashPayments | -17.29M | -13.60M | -6.77M | |
| OtherCashPaymentsfromOperatingActivities | -17.29M | |||
| PaymentsonBehalfofEmployees | -13.60M | -8.97M | ||
| PaymentstoSuppliersforGoodsandServices | -6.77M | |||
| ClassesofCashReceiptsfromOperatingActivities | 1.01M | 782.38K | 1.51M | |
| OtherCashReceiptsfromOperatingActivities | 1.01M | 782.38K | 82.81K | |
| ReceiptsfromCustomers | 0.00 | 0.00 | 1.51M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for IXHL
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|